CorTec’s CEO Says FDA Breakthrough Marks Shift To Therapeutic BCI For Stroke

 
• By Marion Webb
  
Germany-based CorTec GmbH has received US FDA beakthrough device designation for its brain-computer interface (BCI) system designed to restore motor function in stroke patients.

More from Medtech Insight

More from Regulation